Apoptosis of Nerve Cells. Trigger Pathways and Molecular Markers

Review Article | DOI: https://doi.org/10.31579/2690-8808/0188

Apoptosis of Nerve Cells. Trigger Pathways and Molecular Markers

  • Maksimovich N.Ye
  • Elizaveta I. Bon *

Grodno State Medical University, 80, Gorkogo St., 230009, Grodno, Republic of Belarus.

*Corresponding Author: Elizaveta I. Bon, Candidate of biological science, assistant professor of pathophysiology department named D.A. Maslakov, Grodno State Medical University; 80, Gorky St., 230009, Grodno, Belarus.

Citation: Maksimovich N.Ye. and Elizaveta I. Bon, (2024), Apoptosis of nerve cells. Trigger pathways and molecular markers. J, Clinical Case Reports and Studies, 5(2); DOI:10.31579/2690-8808/0188

Copyright: © 2024, Elizaveta I. Bon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 13 March 2024 | Accepted: 21 March 2024 | Published: 28 March 2024

Keywords: apoptosis; cell death; markers; mechanisms

Abstract

Most of the biochemical varieties of accidental and regulated cell death fit into four morphological types: apoptosis, autophagic death, senescence, necrosis, and mitotic catastrophe. The information presented in the work on the functional features of cell death will serve as a fundamental basis for further study of destructive processes in cytology with the subsequent implementation of the results obtained into clinical practice.

Summary

Apoptosis is a regulated cell death involving a genetically programmed molecular mechanism that can be modulated by pharmacological or genetic influences. The phenomenon of apoptosis plays an important role in the destruction of cells during embryogenesis and organogenesis, as well as during the involution of organs and tissues in an aging organism, during the immune response and other processes [1,4,7,14]. Apoptosis is an energy-dependent process and, as a rule, is not accompanied by the development of an inflammatory reaction [14]. 

Morphological features of apoptosis:

Apoptosis is manifested by chromatin condensation, DNA fragmentation and nuclear disintegration (karyorrhexis), rounding of cells, retraction of processes, loss of microvilli, loss of folding of the cytoplasmic membrane, protrusion of sections of the outer cytoplasmic membrane (blebbing), which often ends in the formation of membrane microparticles [1,4,5,7,13,14,25].

Until the late stages of the process, the integrity of the membrane is preserved, the size of the cell decreases and its subsequent fragmentation into membrane vesicles with intracellular contents - apoptotic bodies, which are subsequently phagocytosed by macrophages and neighboring cells [1,4,5,7,17,21]. A cell during apoptosis decreases in size, its cytoplasm becomes denser. Organelles are arranged more compactly. It is assumed that changes in the shape and volume of the cell are a consequence of the activation of the transglutaminase enzyme, which causes the formation of cross-links between cytoplasmic proteins, which leads to the formation of a kind of shell under the cell membrane [14,15,17]. The most characteristic manifestation of apoptosis is the condensation of chromatin along the periphery of the nucleus with the formation of clearly defined seals of various shapes and sizes. In this case, the core can be torn into two or more fragments [7,14,15,19,25]. Chromatin condensation is caused by the cleavage of nuclear DNA by the action of calcium-dependent endonuclease at the sites that bind individual nucleosomes, which leads to the formation of a large number of fragments [7,14,15,19,21,25]. In the cytoplasm, cavities and apoptotic bodies are formed, consisting of densely packed organelles, with or without nuclear fragments [14,15]. Immunohistochemical markers of apoptosis are apoptosis inducing proteins (Bad, Bax), apoptosis inhibitory proteins (Bcl-2, Bcl-XL). Also often determined are antibodies to the p53 protein, cytokeratin-18 cleavage products (C-CK18), activated caspases-3, -1 and -7, phosphorylated histone Н2АХ (gammaH2AX), poly-ADP-ribose polymerase (PARP-C), apoptosis inducing factor (AIF). Annexin V binding sites are also determined [7,14, 15,19].

Physiological role of apoptosis:

- controls the number of cells in organs and tissues;

- participates in the regulation of the body's immune mechanisms:

• elimination of virus-infected cells;

• tumor cells (interaction of Fas-R and Fas-L);

• activity of the inflammatory process and immune response by stimulating the death of activated T-lymphocytes;

• prevents the development of autoimmune damage to trans-barrier organs (testis, eyes) that have Fas-L receptors that interact with Fas-R autoreactive T-lymphocytes, penetrating into them, die due to apoptosis due to their interaction with lymphocytes;

• elimination of autoreactive T- and B-lymphocytes [14,21].

Reasons for apoptosis:

1. programmed cell death during embryogenesis;

2. hormone-dependent involution of organs;

3. elimination of individual cells in tumors during its regression or active growth;

4. death of lymphocytes after depletion of cytokines;

5. pathological atrophy of hormone-dependent organs (atrophy of the prostate gland after castration);

6. pathological atrophy of parenchymal organs after obstruction of the excretory ducts;

7. action of cytotoxic T-lymphocytes (graft rejection);

8. the effect of damaging factors in small doses (viruses, temperature, ionizing radiation, antitumor drugs) [1,4,5,7,14,21,25].

The following stages of apoptosis are distinguished:

1. stage of induction (features depend on the nature of the stimulus acting on the cell);

2. effector stage (intracellular mechanisms of cell death are switched on);

3. stage of degradation (destruction of vital cellular components with the appearance of morphological signs of apoptosis) [14].

The implementation of apoptosis occurs with the participation of enzymes - caspases.

There are two groups of caspases:

• initiating caspases (2, -8, -9, -10), which are activated in response to the action of stimuli that trigger apoptosis;

• effector caspases (3, -6, -7) are activated by initiating caspases [22].

Caspases are cysteine proteases that cleave substrates at the location of aspartic residues in the molecule [22].

The targets for effector caspases are:

• proteins involved in transcription and DNA repair, such as poly-(ADP-ribose) polymerase;

• core proteins (laminin A);

• cytoskeletal proteins (fodrin and gelsolin);

• DNase inhibitor [22].

Caspase function is controlled by a family of proteins called "protein inhibitors of apoptosis". Members of this family of proteins bind to caspases-3, -7 and -9 and inhibit their activation [22].

Ways to trigger apoptosis:

1. through the activation of "death receptors" (DR);

2. mitochondrial (release of cytochrome c into the cytoplasm, activation of APAF-1 (apoptotic protease activating factor) and formation of the apoptosome, mediated action of the p53 protein);

3. through the cell membrane: mediated by the "perforin-granzyme" system;

4. by expression of apoptosis promoter genes Bad, Bax, Rb, р53 or inhibition of anti-apoptotic genes - Bcl, Bcl-XL, etc [4,7,14,15,19].

The way to trigger apoptosis through the activation of membrane "death receptors"

Cell membranes have special "death receptors" (DR - Death Receptors). These include the Fas receptor (Fas-R), the receptor for tumor necrosis factor-α (TNF-R) and the death receptors DR3, DR4 and DR5 [4,7,14,15,25]

The interaction of Fas-Ligand (Fas-L) with Fas-R, TNF-α with TNF-R or TRAIL (TNF-related apoptosis inducing ligand, TNF-α-related apoptosis inducing ligand), with DR4 or DR5 causes aggregation of these receptors. Fas-L is a cell membrane protein of the TNF family, present on cytotoxic T-lymphocytes and NK-cells, as well as on cells of "immune-privileged organs" and on cells of malignant tumors. It can temporarily appear on other cells under the influence of pro-inflammatory cytokines[14,15].

After the interaction of the death receptor with the corresponding ligand, aggregation of death receptors occurs, after which special adapter proteins are sent to the cytoplasmic regions (domains) of aggregated death receptors: FADD (Fas-associated protein with death domain), TRADD ligands (TNF-R-adapter-protein with death domain) that interact with TNF-R. The resulting complex activates the initiating caspases (pro-caspase-8 or -10), which activate first the effector caspase-3, and then caspases-6 and -7.

Mitochondrial pathway for triggering apoptosis

There is a mitochondrial mechanism for enhancing the function of effector caspases. At the same time, caspase-3 in the active state cleaves the Bid cytoplasmic protein, which then moves to the mitochondria and integrates into the membrane, which leads to the release of cytochrome c from the mitochondria into the cytosol. Cytochrome c interacts with APAF-1 and pro-caspase-9 to activate the latter and activate pro-caspase-3, which in turn activates caspases-6 and 7 [4].

The reasons that trigger apoptosis through a change in mitochondrial function are:

• deficiency of growth factors in the environment surrounding the cell;

• increase in the formation of reactive oxygen species in the cell;

• DNA damage;

• the effect of glucocorticoids on lymphocytes, thymocytes, etc [4].

Under the influence of these stimuli, the function of proteins belonging to the Bcl-2 family changes. The proteins of this family are divided into two classes [14,15].

Proteins of the first class inhibit apoptosis. They are embedded in the outer membrane of mitochondria and regulate membrane permeability, as well as reduce the formation of ROS. Representatives of this class of proteins are Всl-2 and Всl-хL [1,14,15,19].

Proteins of the second class of the Bcl-2 family stimulate the development of apoptosis. These proteins are located in the cytosol, but then move to the mitochondrial membrane, where they interact with the representatives of the first class - Bcl-2 and Bcl-xL proteins, inhibiting them. Members of the class II proteins of the Bcl-2 family are Bid, Bad, Bax, and others [1,7,14,15,19]. Activation of representatives of the second class Bcl-2 causes an increase in the permeability of the inner mitochondrial membrane, which leads to swelling of the mitochondrial matrix and rupture of the outer membrane. When the function of members of the Bcl-2 family that inhibit apoptosis is suppressed, a “non-selective megachannel” can form in the mitochondrial membrane, which increases membrane permeability, which leads to the release of cytochrome c and the DIABLO protein from mitochondria into the cytosol [1, 7,14,15,19-25]. Cytochrome c that enters the cytosol interacts with APAF-1, attracting caspase-9, which leads to the formation of a protein complex, the apoptosome. In the presence of ATP, caspase-9 is activated. The DIABLO protein inactivates protein inhibitors of apoptosis, which leads to the activation of caspase-3 [1,13-15,19,25].

The pathway of apoptosis triggering by the "perforin-granzyme" system

This apoptosis triggering pathway plays a role in the mechanism of target cell death under the influence of cytotoxic T-lymphocytes and NK cells, participating in the body's defense against viruses, tumor cells, as well as in the mechanisms of autoimmune tissue damage and transplant rejection [4,14]. After recognition of the target cell, cytotoxic T-lymphocytes and NK cells, using perforin, cause the formation of a pore in its plasma membrane, through which granzyme B enters, activating caspase-3[4,14,22].

Apoptosis initiation pathway associated with the action of р53 protein and other apoptosis promoters

The р53 protein, which plays an important role in the mechanisms of cell protection against damage, is constantly formed in various cells. In normal cells, the content of the р53 protein is negligible due to its rapid degradation after formation. DNA damage causes stabilization of the р53 protein, which increases its concentration in the cytosol [1,4,5,7,13,14,17,21,25]. The р53 protein is a transcription factor. It can bind to the promoters of a number of important genes: to the p21 protein gene, activating it, which leads to the formation of its product, which inhibits cyclin-dependent kinases that “stop” the cell at the G1 or G2 stage of the cell cycle [1,4,5,7,13,14, 15, 17,21,25]. When DNA repair fails, р53, through the activation of the corresponding gene, increases the formation of the Bax protein, which triggers apoptosis by changing the function of mitochondria. The р53 protein also stimulates the formation of reactive oxygen species, which change the state of the mitochondrial membrane and cause the release of cytochrome c into the cytosol. In addition, when DNA repair is impaired, the р53 protein increases the formation of Fas-R, facilitating its transport from the Golgi complex to the cell membrane, which activates apoptosis under the influence of the Fas ligand [1,4,5,7,13,14,15,17,21,25].

Recognition of apoptotic cells and apoptotic bodies by phagocytes

Intracellular phenomena during apoptosis lead to asymmetry of cell membrane phospholipids. As a result, phosphatidylserine appears in the outer lipid layer of apoptotic bodies, which under normal conditions is located in the inner lipid layer of the membrane. Phosphatidylserine is recognized by scavenger receptors on phagocytes. These receptors can also recognize altered LDL and other polyanionic ligands [1,4,7,14,15,17,21,25]. Recognition of apoptotic cells by phagocytes can also occur through CD36 receptors. First, phagocytes secrete thrombospondin, which binds to CD36. Thrombospondin then binds to the appropriate sites on the surface of apoptotic cells. In addition, receptors for the C1q component of the complement system and a receptor for vitronectin are involved in the recognition of apoptotic cells [1,4,5,13,14,15,17,25].

After recognition of apoptotic cells and apoptotic bodies, they are taken up by phagocytes. At the same time, phagocytosis of apoptotic bodies is not accompanied by the formation of substances that stimulate the development of inflammation. On the contrary, phagocytes form substances with anti-inflammatory action: transforming growth factor 1, prostaglandin E2 and interleukin-10 [7,15,19].

Approaches to the classification of damage and death of nerve cells

With the development of the process of neurodegeneration, the death of predominantly nerve cells and the activation of the glial component of the nervous tissue occur. The vast majority of neurons during the development of the neurodegenerative process die not from the direct impact of the lethal factor, although its action at the initial stages is not excluded, but as a result of the gradual depletion of defense mechanisms and the activation of the self-destruction program [1,10,19,24].

The first studies of irreversible destructive changes occurring in cells began to be carried out shortly after the development of the cellular theory by M. Schleiden, T. Schwann (1838). In the study of cell death in the nervous system, R. Virchow (1858) identified two types of degenerative processes: passive "necrosis" and the active process of cell destruction in "living tissues" - "necrobiosis" (Clarke P. G., 2012). R. Virchow's classification to a certain extent corresponds to modern concepts of necrosis and apoptosis [1,10,14,19,24]. In 1990, P. G. Clarke proposed a classification of types of cell death that is currently relevant: I - apoptosis, II - autophagy, III - non-lysosomal cell death - corresponds to necrosis. In 2005, the Nomenclature Committee on Cell Death (NCCD) recommended a classification that further characterized other variants of cell death. According to modern concepts, a cell can be considered dead if one of three morphological and molecular criteria is identified: loss of the integrity of the cytoplasmic membrane, complete fragmentation of the cell (including its nucleus) with the formation of individual apoptotic bodies, and absorption of the dead cell (or its fragments) by another cell [14]. The modern classification of cell death (apoptosis, necrosis, autophagy, senescence, mitotic catastrophe) is based on morphological manifestations of cell death, molecular (biochemical) criteria (intracellular processes occurring with or without participation of various proteases and nucleases), functional aspects (regulated or accidental death, physiological or pathological) and immunological characteristics of the process (immunogenic and non-immunogenic cell death) [1,10,19.24]. All types of cell death fit into two main non-overlapping groups: regulated cell death and accidental (random) cell death. Accidental cell death occurs as a result of physical (elevated temperature, high pressure), chemical (uncompensated changes in pH level) and mechanical damaging factors. This type of cell death develops rapidly and is resistant to the effects of pharmacological agents. The concept of "accidental cell death" is close to the more widely used concept of "necrosis"[13,14,25].

To accurately determine the type of cell death, it is necessary to use morphological methods, primarily electron microscopy. A combination of at least two research methods is recommended: a method for visualizing morphological changes and determining biochemical changes inside the cell [1,10,19,24].

Biochemical classification and features of neuronal apoptosis types

According to the biochemical classification, there are several different mechanisms of neuronal apoptosis that have similar morphological manifestations: perikaryon swelling, neuropil destruction, chromatin condensation, DNA fragmentation followed by karyorrhexis [14,21]. The external (receptor) mechanism of apoptosis is induced by extracellular stress signals that are perceived by specific transmembrane receptors [21].

The initiating factors of the mechanism involving the internal pathway of apoptosis are intracellular changes, such as DNA damage, oxidative stress, cytosolic calcium overload, excitotoxicity (hyperstimulation of glutamate receptors in the nervous system), accumulation of denatured proteins in the endoplasmic reticulum, and others. The main mechanism for the development of the internal pathway of apoptosis is an increase in the permeability of mitochondrial membranes. This type of cell death can be caspase dependent or independent of caspases [21]. By caspase-dependent cell death, as a rule, we understand the process carried out by caspases and suppressed by their broad-spectrum inhibitors, for example, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-FMK) [21,22]. The caspase-independent pathway of cell death is characterized by chromatin lysis and is accompanied by depletion of NAD+ and ATP [21,22]. Excitotoxicity refers to neuronal-specific mechanisms of cell death, which occurs with excessive or prolonged activation of excitatory amino acid receptors (aspartate, glutamate). Overactivation of NMDA (N-methyl-D-aspartate) glutamate receptors leads to changes in the level of intracellular calcium, depolarization of the mitochondrial membrane, an increase in free radicals, and activation of caspases. Also, activation of glutamate receptors leads to an increase in the level of cAMP and the release of Ca2+ from intracellular depots. The toxic effect of glutamate contributes to the deposition of β-amyloid in the brain, and the activation of NMDA receptors leads to pathological phosphorylation of the τ-protein, the main component of neurofibrils. The death of neurons as a result of excitotoxicity is a mixed form of cell death, combining signs of necrosis and apoptosis. The early stages of cell death are characterized by swelling, vacuolization of the cytoplasm and destruction of the membrane, i.e., they are manifested by signs of necrosis. However, excitotoxicity results in internucleasome DNA degradation, chromatin fragmentation and condensation, and caspase activation, which is typical of apoptosis. Excitotoxicity, as a type of cellular degeneration, is involved in the pathogenesis of cerebral ischemia, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, and a number of other neurodegenerative diseases [8,10,19]. Ferroptosis is an iron-dependent form of regulated cell death, controlled by glutathione peroxidase-4 and glutathione-dependent enzyme. With ferroptosis, the density of mitochondrial membranes increases and a decrease in their size is observed [8,10,19].

Apoptosis dysregulation

Dysregulation of apoptosis is manifested by its enhancement or suppression [14,15,21]. Suppression of apoptosis can lead to an increase in cell survival. This contributes to tumor growth and the development of autoimmune diseases [14]. Activation of apoptosis increases the likelihood of cell death. In this regard, apoptosis is involved in tissue and organ cell damage in: neurodegenerative diseases characterized by loss of neurons, ischemic damage to the myocardium and other organs, HIV-infection [8,10,14,15,19,21].

Pathology of apoptosis:

Mutation of the TNF-R1 gene leads to the development of "congenital periodic fever syndrome" due to a violation of the mechanism of suppression of the cell response to TNF. Altered TNF-R1 is expressed on leukocytes, but its removal from the membrane is impaired. At the same time, the content of the soluble form of TNF-R1 in the blood decreases, but it retains the ability to bind TNF, competing with cellular TNF-R1 for TNF. Symptoms of "familial periodic fever" are attacks of transient fever, inflammation of the serous and synovial membranes, myalgia, periorbital edema, pain in the scrotum, inguinal hernia [1,7,13,14,15,17,18,19,21].

Mutations of the Fas-R gene can lead to changes in the structure of the extra- and intracellular parts of the receptor. Fas-R mutations are most common in bladder tumors, Hodgkin's disease, and tumors of the stomach and intestines. Fas-R mutations provide resistance of tumor cells to NK cells and T-lymphocytes, which allows them to express their own Fas-L at a high level for protection against the body's immune system and invasion into surrounding tissues [1,7,13,14,15,21].

Mutation of the Fas-R gene also leads to the development of type I lymphoproliferative syndrome (ALPS I), accompanied by proliferation of lymphocytes and autoimmune organ damage. Patients present with splenomegaly and hepatomegaly, enlarged lymph nodes, immunoglobulinemia, lymphocytosis, and lymphomas. At the same time, lymphocytes are resistant to death stimulated by the interaction of Fas-L with Fas-R [1,7,13,14,15,18,19,21].

Mutations in the Fas-L gene result in a lymphoproliferative syndrome similar to systemic lupus erythematosus [1,7,13-19,21].

Mutation of the perforin gene leads to familial hematophagocytic lymphohistiocytosis. The disease begins in childhood and is characterized by an increase in the content of activated lymphocytes and monocytes. There is an increased expression of pro-inflammatory cytokines: γ-interferon, interlNikithaeukin-1, interleukin-6 and TNF. The cytotoxic effect of T- and NK-cells is impaired. The disease is manifested by fever, frequent viral infections, pancytopenia and hepato-splenomegaly [1,7,13-19,21].

Mutation of the caspase-10 gene leads to the development of type II autolymphoproliferative syndrome (ALPS II). The function of lymphocytes and dendritic cells is disturbed, they accumulate in the paracortical zones of the lymph nodes. Dendritic cells become resistant to apoptosis. The regulation of the immune response is disrupted. The main manifestations of the syndrome: lymphadenopathy, hepato-splenomegaly, hyperimmunoglobulinemia with the presence of a large number of autoantibodies, with autoimmune hemolytic anemia and lymphocytosis [1,7,13-19,21].

Mutation of the Bcl-10 gene (B-cell lymphoma leukemia 10) leads to the development of Bcl-10 resistance to apoptosis signals, disruption of the mechanism of NF-kB activation and stimulation of cell proliferation [1,7,13-19,21].

Mutations in the р53 gene provide cell resistance to apoptosis [1,7,13-19,21].

Mutations of the Bax gene are observed in tumors of the intestine and blood system and also contribute to cell resistance to apoptosis [7,13-19,21].

Mutations in the Bcl-2 gene cause its excessive expression and increase resistance to apoptosis [1,7,13-19,21].

Mutations in the inhibitor apoptosis protein (IAP-2) gene are observed in lymphomas and lead to a more pronounced inhibitory effect of IAP on caspases, blocking apoptosis [1,7,13-19,21].

Mutations of the NAIP-1 gene. The NAIP-1 protein belongs to the IAP protein family and is localized in the neurons of the nervous system. Mutations in the gene encoding lead to the development of spinal muscular atrophy associated with the death of neurons in the anterior horns of the spinal cord [1,7,13-19,21].

Necrosis is a process of cell death, which is characterized by cell swelling (oncosis), violation of the integrity of the plasma membrane, degradation of organelles and DNA [9,13,25].

Necrosis is an irreversible post-mortem change in a cell, consisting in the gradual enzymatic destruction and denaturation of its proteins. It develops with excessive alteration of the cell, does not require energy expenditure and does not depend on regulatory signals of local and central origin. Necrosis is usually established by the destruction of cell membranes using electron microscopy. The causes of violent cell death (necrosis) can be:

• depriving her of food and oxygen;

• the action of various pathogenic agents leading to irreversible changes in structure and function with inhibition of the most important metabolic processes [9,13,25].

Necrosis is preceded by a deep, partially irreversible stage of cell damage - necrobiosis. Despite the variety of etiological factors that provoke the development of necrobiosis and necrosis, molecular and cellular changes detected during cell death are in most cases of the same type. Allocate hypoxic and free-radical necrobiosis. Hypoxic necrobiosis is initiated by various pathogenic factors that cause prolonged hypoxia. The mechanisms of free-radical cell damage can be triggered without hypoxia, and sometimes even in conditions of excess oxygen. Both types of necrobiosis can be combined and complement each other. Their outcome is damage to the cell, in which it is not capable of independent energy supply and subsequently undergoes necrosis [9,13,14,25].

The main differences between apoptosis and necrosis are:

• maintaining the integrity of the cell membrane with an increase in its permeability only for substances of small molecular weight;

• cell size reduction (cell wrinkling);

• absence of swelling of cellular organelles;

• condensation of cytoplasm components, not its lysis;

• the need for energy supply [9,14,15,23,25].

There are two main types of necrosis:

• coagulation (dry) necrosis, in which acidosis develops in the cell, protein coagulation occurs, calcium accumulation and aggregation of cytoskeletal elements are noted. This type of necrosis is often observed in severe hypoxia, is predominantly noted in tissues rich in protein and calcium, and is characterized by early and irreversible damage to mitochondria [13,23];

• colliquational necrosis, which is characterized by the predominance of hydrolytic processes of lysosomal autolysis or heterolysis with the participation of phagocytes. At the same time, the focus of necrosis is softened, the formation of hydroxyl radicals and endogenous saponification of cells are observed, which leads to the destruction of its structures, including membranes [13,23].

• There are no clear boundaries between coagulation and colliquation types of necrosis [13,23,25]. The information presented in the work on the functional features of cell death will serve as a fundamental basis for further study of destructive processes in cytology with the subsequent implementation of the results obtained into clinical practice.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad

Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.

img

Gomez Barriga Maria Dolores

The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.

img

Lin Shaw Chin

Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.

img

Maria Dolores Gomez Barriga